Case study: Caring for expectant mothers with substance use disorder
With the country in the grips of an opioid epidemic, Norton Healthcare in 2015 launched the Maternal Opiate and Substance Treatment program, which makes it easy and non-stigmatizing for pregnant women with substance use disorder to access addiction treatment during obstetrical care, dramatically reducing admissions for neonatal abstinence syndrome. Read more.
Related News Articles
Headline
The Senate Sept. 18 passed the AHA-supported SUPPORT Act (H.R. 2483) by a voice vote, advancing the bill to President Trump to sign into law. The bill…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Blog
Every pregnant woman deserves access to high-quality maternal care — from conception through postpartum. Yet in parts of the country, some of that care is…